CSPC Innovation Pharmaceutical Co Ltd Class A (300765) — Cash Flow Quality Index
CSPC Innovation Pharmaceutical Co Ltd Class A (300765) has a Cash Flow Quality Index of -2.69x as of June 2025. Operating cash flow of CN¥-65.01 Million is below net income of CN¥24.16 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore CSPC Innovation Pharmaceutical Co Ltd Cl total assets for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
CSPC Innovation Pharmaceutical Co Ltd Class A Cash Flow Quality Index (2014–2023)
Historical Cash Flow Quality Index for CSPC Innovation Pharmaceutical Co Ltd Class A across 10 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 300765 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for CSPC Innovation Pharmaceutical Co Ltd Class A (2014–2023)
Year-by-year earnings quality comparison for CSPC Innovation Pharmaceutical Co Ltd Class A. For live market cap and the full company financial profile, see market value of CSPC Innovation Pharmaceutical Co Ltd Cl.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | 1.23x | CN¥927.24 Million | CN¥755.56 Million | ▲ +39.2% |
| 2022 | 0.88x | CN¥640.72 Million | CN¥726.61 Million | ▲ +18.6% |
| 2021 | 0.74x | CN¥292.09 Million | CN¥392.70 Million | ▼ -36.1% |
| 2020 | 1.16x | CN¥349.07 Million | CN¥299.71 Million | ▲ +1.0% |
| 2019 | 1.15x | CN¥315.38 Million | CN¥273.53 Million | ▲ +61.9% |
| 2018 | 0.71x | CN¥159.73 Million | CN¥224.32 Million | ▲ +10574.1% |
| 2017 | 0.01x | CN¥1.30 Million | CN¥194.91 Million | ▼ -99.0% |
| 2016 | 0.67x | CN¥137.27 Million | CN¥206.36 Million | ▼ -31.4% |
| 2015 | 0.97x | CN¥112.05 Million | CN¥115.48 Million | ▲ +12.5% |
| 2014 | 0.86x | CN¥93.36 Million | CN¥108.24 Million | — |